Document is current

Any future updates will be listed below

Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study

Crossref DOI link: https://doi.org/10.1186/s12933-017-0621-8

Published Online: 2017-10-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark